Tag

According to the release, expanding ART access is at the core of a new set of targets for 2020 with the aim to end the AIDS epidemic by 2030.

The expanded use of antiretroviral treatment is supported by recent findings from clinical trials confirming that early use of ART keeps people living with HIV alive, healthier and reduces the risk of transmitting the virus to partners.

One survey suggested that approximately 10% of women in American who are premenopausal suffer from the condition, which is called hypoactive sexual desire disorder.

Sprout bought it from a German company which had given up after the FDA rejected an application in 2010.

The FDA followed that recommendation earlier this week, approving Addyi with a boxed warning and other safety measures to address side effects like dizziness, low blood pressure and fainting. “I’m hopeful not only for what it could mean for women in which it could...

This has prompted the FDA to require the drug’s manufacturer to include a strong “boxed warning” to notify patients who drink alcohol and have liver problems not to take Addyi.

Sprout Pharmaceuticals – the company that on Wednesday won approval to sell its female libido drug “Addyi” in the US – wants to start working with worldwide drug regulators to market the product globally.

The “female Viagra” Flibanserin, designed to treat women’s low sexual desire, finally receives approval from FDA on Tuesday, after two rejections. There’s a warning of serious side effects such as low blood pressure, fainting and fatigue. It is intended to...

This syndrome may develop in women who had no prior problems with their libido and occur regardless of the type of sexual activity or situation with the partner, says the FDA.

The Food and Drug Administration has sexual-health/fda-approves-says-no-female-viagra-n411711″ target=”_blank”>approved the first prescription drug aimed at boosting women’s libido, but don’t go calling the new pink pill the “female...

Compared to a fake treatment (placebo), Addyi was tied to 0.5 more satisfying sexual events per month on average.

The drug, which is produced by Sprout Pharmaceuticals, is intended to treat sexual-health/hypoactive-sexual-desire-disorder.aspx” target=”_blank”>hypoactive sexual desire disorder (HSDD) – where a sufferer’s lack of sexual desire is causing them...

For some workers however, checks against cancer might be on the cards too.

Prostate cancer is five different diseases, say British researchers who suggest the ability to distinguish between the different types can help doctors in the future more effectively treat cases.

Prostate cancer is the most common cancer in men in the UK, with more than 40,000 diagnosed every year. “These findings could help doctors decide on the best course of treatment for each individual patient, based on the characteristics of their tumour”.